Intravenous Solution Market Innovations and Technological Improvements 2019 | Size, Growth, Trends, Demand, Key Components, Market Leaders and Share For IV Therapy and Global Industry Forecast To 2022

Global Intravenous (IV) Solution Market: Information by Types (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral lipid Emulsion and other Solutions), End Users (Hospital & Clinics, Ambulatory and Home Care) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2022

Intravenous (IV) Solution Market Analysis 

The global intravenous solution market is predicted to touch USD 11,511.2 million at a 7.69% CAGR over the forecast period (2016-2022), as stated by the latest Market Research Future (MRFR) report. Intravenous solutions are fluids that are delivered into the vein directly. It is the fastest means of delivering fluid replacement and medications throughout the body as they are directly introduced into the circulation. Such intravenous solutions are generally offered to patients whose body nutrients or fluid volume decreases. 

FREE SAMPLE COPY OF Intravenous (IV) Solution Market  @

Various factors are propelling the intravenous solution market growth. These factors, as stated by the latest MRFR report, include growing incidences of chronic diseases especially cholera, increasing acceptance of vitamin C IV for colorectal cancer, increasing research and development funding, increasing healthcare expenditure, rapidly growing healthcare infrastructure and advancement in technology transpired in medical science. Additional factors pushing market growth include growing population, growing geriatric populace worldwide, investments and seminal efforts transpired to develop an intravenous solution, and improving economic conditions that are enabling access to improved healthcare and quality life. 

On the contrary, increasing prices of vitamin C intravenous therapy and strict government regulations are factors that may deter the intravenous solution market growth over the forecast period. 

Intravenous (IV) Solution Market Segmentation

The MRFR report provides a complete segmental analysis of the intravenous solution market report on the basis of type, nutritional content, and end users. 

Based on type, the intravenous solution market is segmented into total parenteral nutrition and peripheral parental nutrition. Of these, the total parenteral nutrition segment will have the largest share in the market over the forecast period. 

Based on nutritional content, the intravenous solution market is segmented into parenteral lipid emulsion, vitamins and minerals, carbohydrates, amino acid solution, and others. Of these, the amino acid solution segment will dominate the market over the forecast period. 

Based on end users, the intravenous solution market is segmented into ambulatory and home care and hospitals and clinics. 

Intravenous Solution Market – Geographical Analysis

Globally, North America region is the leading market for Intravenous Solution, accounting for the largest revenue pocket, followed by the Europe & Asia Pacific markets, respectively. Attributing to the high IV consumption rate due to the high prevalence of chronic diseases is predominantly driving the market growth.

The US market backed by the high healthcare expenditure account for the largest contributor to the market growth in the region. Moreover, increasing prevalence of immunodeficiency disorder and rising demand for treatment measures provide impetus to the market growth.

Europe region stands as the second-largest market for intravenous solution, worldwide. The market is fostered by the high per capita income and robust proliferation of healthcare sector in the region. Growing markets in the countries like Germany & France drive the market growth in the region, at a large scale. Attributing to the increasing investment in health care and the rising number of patients with chronic diseases, the market is projected to witness a phenomenal CAGR during the forecast period.

Asia Pacific market for the intravenous solution is expected to perceive an exponential growth. Due to the huge population and the burgeoning medical treatment market, India & China drive the market growth in the region. Furthermore, owing to the emergence of high-quality and better healthcare infrastructure and institutions, the APAC Intravenous Solution Market is estimated to register a CAGR of 8.34% during the forecast period (2016 to 2022).


Intravenous (IV) Solution Maket Analyzed by Top Key Players 

Leading players profiled in the intravenous solution market report include Grifols S.A. (Spain), Terumo Medical Corporation (Tokyo), Amanta Healthcare (India), Baxter (U.S.), Fresenius Kabi AG (Germany), Braun Melsungen AG (Germany), and ICU Medical, Inc. (U.S.), among others. Various strategies such as research and development, joint ventures, mergers and acquisitions, and product innovations have been adopted by key players to strengthen their foothold in the market. 

May 2019: Sihuan Pharmaceutical Holdings Group Ltd is the first company that has received drug registration approval in China for sodium chloride/ceftazidime injection. Currently, this solution is a highly advanced formulation of intravenous solutions that has significant strengths during extreme situations and emergencies. This has been recognized as the most convenient and safest infusion product, which is regarded as a new formulation having excellent development potential in the pharmaceutical domain. 


About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India